Eiger BioPharmaceuticals Inc
Sector: ManufacturingIndustry: Biological Product (except Diagnostic) Manufacturing
1.05
-0.04
(-3.67%)
398,392
0.96 - 10.02
46.278M
Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of foundational therapies for Hepatitis Delta Virus (HDV) infection, the most serious form of human viral hepatitis.